Beijing Chunlizhengda Sets Final Dividend and Clarifies H-Share Tax Treatment
I'm LongbridgeAI, I can summarize articles.Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced a final cash dividend of RMB 1.5 per 10 shares for the fiscal year ending December 31, 2025, to be paid in HKD for H shareholders. The payment is scheduled for June 30, 2026, with a tiered withholding tax for non-resident shareholders ranging from 10% to 20%. This decision emphasizes the company's commitment to capital returns and addresses cross-border tax considerations for investors.
Memorial Day Sale – Claim 70% Off TipRanks
- Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis.
- Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter
Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H ( (HK:1858) ) has shared an announcement.
Beijing Chunlizhengda Medical Instruments Co., Ltd. has announced a final ordinary cash dividend of RMB 1.5 per 10 shares for the financial year ended 31 December 2025, approved at its 2024 annual general meeting and A shareholders’ class meeting. For H shareholders, the dividend will be paid in Hong Kong dollars at HKD 1.71775 per 10 shares, with an exchange rate set at RMB 1 to HKD 1.14516 and payment scheduled for 30 June 2026.
The company detailed a tiered withholding tax arrangement for non-resident enterprise and individual H shareholders and mainland investors accessing H shares via Stock Connect, with tax rates ranging from 10% to 20%. This dividend decision and clarified tax treatment provide income visibility for shareholders and underline the company’s ongoing commitment to capital returns, while also highlighting the cross-border tax considerations facing investors in its H shares.
More about Beijing Chunlizhengda Medical Instruments Co., Ltd. Class H
Beijing Chunlizhengda Medical Instruments Co., Ltd. is a Hong Kong-listed medical device manufacturer operating through H shares. The company focuses on producing and marketing medical instruments, serving healthcare institutions and investors in mainland China and international markets through its cross-border shareholding structure.
Average Trading Volume: 891,607
Technical Sentiment Signal: Sell
Current Market Cap: HK$6.49B
Find detailed analytics on 1858 stock on TipRanks’ Stock Analysis page.